Skip to content

Discontinued — last reported Q4 '24

Total Revenue at other companies

Pfizer logo
PfizerPFE
$14.45B+5.4%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$6.56M
Arcus Biosciences logo
Arcus BiosciencesRCUS
$17M-39.3%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$0-100%
Incyte logo
IncyteINCY
$1.27B+20.9%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$108.39M+83.8%

Other financials

Income statement

See full
Operating income-$15.6M+8.1%
Net income-$15.2M+4.8%
EPS (diluted)-$1.11+6.7%

Balance sheet

See full
Cash & equivalents$192.1M+98.7%
Total debt$409.0K-57.2%
Total equity$184.4M+103%
Total assets$198.7M+98.9%

Cash flow

See full
Operating cash flow-$12.9M+7.6%
CapEx$5.0K-72.2%
Free cash flow-$12.9M+7.7%

Valuation

See full
Market cap$184.2M+71.8%
Enterprise value-$7.49M-130%

Returns & leverage

See full
Return on equity-42.7%
Debt / equity0.0×
Current ratio13.8×+2.6×

Where this comes from

Reported directly by OnKure Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: OnKure Therapeutics, Inc.’s 10-K, filed March 10, 2025, on SEC EDGAR. View the filing →

Ask your AI about OnKure Therapeutics, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OnKure Therapeutics, Inc.'s total revenue?
OnKure Therapeutics, Inc. (OKUR) reported total revenue of $0 in Q4 2024.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.